2013年11月12日,美国ACC/AHA相继在线公布了新版的降低心血管疾病风险临床实践系列指南,其中《2013 ACC/AHA降低成人动脉粥样硬化心血管疾病风险之胆固醇治疗指南》[1]一公布便引起了全球医学界的极大关注,《纽约时报》也为此刊发了相关评论报道[2]。1更新要点解读新指南更新要点之一是“不再推荐具体的LDL-C治疗目标值”。LDL-C升高已被证实是冠心病和缺血性脑卒中的独立危险因素之一,降脂治疗的首要目标 On November 12, 2013, the ACC / AHA of the United States published a series of new online guidelines on clinical practice to reduce the risk of cardiovascular disease, including “2013 ACC / AHA Guidelines for Cholesterol Treatment to Reduce Risk of Atherosclerotic Cardiovascular Disease in Adults [1 ] A publication has aroused great concern of the global medical community, ”New York Times“ also published relevant comments for this report [2]. 1 Update Highlights One of the highlights of the new guideline update is ”No longer recommend specific LDL-C treatment targets." Elevated LDL-C levels have been identified as one of the independent risk factors for coronary heart disease and ischemic stroke. The primary goal of lipid-lowering therapy